METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)

QR Code

METABOLIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY WITH THE NEW RADIOPHARMACEUTICAL ⁹⁹ᵐTc-1-thio-D-glucose IN THE DIAGNOSIS AND MONITORING OF THE PRIMARY BREAST LYMPHOMA (CASE REPORT)

The article shows the feasibility of detecting and monitoring primary breast diffuse large B-cell lymphoma using single-photon emission computed tomography (SPECT) with 99mTc-1-thio-D-glucose (99mТс-TG), a new radiopharmaceutical. The innovative radiopharmaceutical makes it possible to evaluate the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ye. A. Dudnikova, V. I. Chernov, A. V. Muravleva, T. L. Kravchuk, R. V. Zelchan, A. A. Medvedeva, O. D. Bragina, Ye. L. Simolina, N. O. Popova, V. V. Vysockaja, N. M. Lukina, V. A. Shatalova, O. V. Shpileva, A. V. Goldberg, V. Ye. Goldberg
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2020-10-01
Series:	Сибирский онкологический журнал
Subjects:	radiopharmaceutical 99mtc-1-thio-d-glucose single-photon emission computed tomography primary breast lymphoma positron emission tomography
Online Access:	https://www.siboncoj.ru/jour/article/view/1589
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS
by: V. I. Chernov, et al.
Published: (2018-09-01)

THE VALUE OF PET/CT IN THE DIAGNOSIS, STADING AND MONITORING OF COLORECTAL CANCER
by: V. I. Chernov, et al.
Published: (2019-09-01)

RADIONUCLIDE METHODS IN THE DETECTION AND FORECAST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS
by: V. I. Chernov, et al.
Published: (2016-12-01)

Determination of the efficiency of single-photon emission computed tomography with 99mTc-HMPAO-labelled leukocytes in the diagnosis of myocarditis: Comparison of scintigraphic and histological data
by: S. I. Sazonova, et al.
Published: (2016-03-01)

SCINTIGRAPHIC ESTIMATION OF THE SYMPATHETIC INNERVATION OF THE HEART AND MYOCARDIAL PERFUSION IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Lishmanov, et al.
Published: (2014-12-01)

EXTRAOSSEOUS ABNORMALITIES AND ARTIFACTS IN SKELETAL SCINTIGRAPHY
by: S. P. Mironov, et al.
Published: (2016-05-01)

SPECT/CT WITH 99MTC-MIBL IN MONITORING OF ESTHESIONEUROBLASTOMA
by: A. S. Krylov, et al.
Published: (2017-06-01)

Avaliação da interação de diferentes concentrações do extrato de gengibre (Gengiber officinale) na marcação de hemácias com 99mTc
by: OSANA DINIZ FERREIRA, et al.
Published: (2020-06-01)

Optimization of planning radionuclide diagnostic tests in osteoscintigraphy
by: N. A. Maksimova, et al.
Published: (2021-03-01)

Evaluation of predictive value and changes of 99mTc-MIBI clearance and myocardial perfusion in patients with heart failure and indications for cardiac resynchronization therapy
by: A. I. Mishkina, et al.
Published: (2025-05-01)

RADIOPHARMACEUTICALS BASED ON THE GLUCOSE DERIVATIVES FOR TUMOR DIAGNOSIS
by: R. V. Zeltchan, et al.
Published: (2018-05-01)

DIFFERENTIAL DIAGNOSIS OF BRAIN GLIOMAS BY POSITRON EMISSION TOMOGRAPHY USING VARIOUS RADIOPHARMACEUTICALS
by: N. A. Kostenikov, et al.
Published: (2016-02-01)

Heterocyclization reactions study of 3-thio and 3-thio-4-amino derivatives of 1,2,4–triazole
by: O. A. Bihdan, et al.
Published: (2017-04-01)

Unusual 99mTc-pyrophosphate accumulation in aortic aneurysm detected by bone scintigraphy
by: S. P. Mironov, et al.
Published: (2016-11-01)

Preclinical dosimetric evaluation of Ixolaris labeled with 99mTc and Translacional Model
by: Sarah Soriano Figueiredo, et al.
Published: (2019-07-01)

Using of 199Tl-сhloride and 99mTc-MIBI in indications and differential diagnostics inflammatory and neoplastic processes of musculoskeletal system
by: A. P. Kourazhov, et al.
Published: (2012-06-01)

Study of the diagnostic efficiency of single-photon emission computed tomography with [<sup>99m</sup>Tc]Tc-1-THIO-D-glucose in visualization of brain tumors
by: R. V. Zelchan, et al.
Published: (2022-11-01)

Unexplained Cardiac Uptake on 99mTc-MDP Bone Scan in a Patient with Prostate Cancer
by: Malik Juweid, et al.
Published: (2025-07-01)

Planar and tomographic imaging dosimetry comparing to develop a new radiopharmaceutical for melanoma therapy
by: Sarah Soriano, et al.
Published: (2020-06-01)

Relationship between left ventricular mechanical dyssynchrony and accelerated 99mTc-MIBI clearance in patients with heart failure
by: A. I. Mishkina, et al.
Published: (2024-06-01)

Inspection of lead aprons damage and evaluation of transmission rate with a 99mTc point-source
by: Nazenin İpek Işıkcı, et al.
Published: (2025-10-01)

Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
by: A. O. Malysheva, et al.
Published: (2020-12-01)

PROSPECTS OF 199TL-CHLORIDE AND 99MTC-MIBI SCINTIGRAPHY IN THE INDICATIONS OF BONE AND SOFT TISSUE SARCOMAS
by: A. P. Kurazhov, et al.
Published: (2016-02-01)

From radiolabeling to receptor quantification: preclinical assessment of [99mTc]Tc-carvedilol as a cardiac β-adrenoceptor probe
by: Hala F. Azhari
Published: (2025-07-01)

An introduction to emission computed tomography /
Published: (1985)

Radiopharmaceuticals: progress and clinical perspectives /
Published: (1986)

ROLE OF POSITRON EMISSION TOMOGRAPHY IN THE HEMODYNAMIC EVALUATION OF BRAIN TUMORS
by: A. A. Stanzhevskiy, et al.
Published: (2016-02-01)

Role and Place of PET/CT in the Assessment of Skin Melanoma Prevalence
by: M. V. Sorokina, et al.
Published: (2022-07-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

POSITRON EMISSION TOMOGRAPHY IN GYNECOLOGIC ONCOLOGY
by: D. V. Ryzhkova, et al.
Published: (2016-02-01)

Regulation of Radiopharmaceutical Products
by: V. V. Kosenko, et al.
Published: (2022-12-01)

Diagnosis of sentinel lymph nodes in patients with cancer of the larynx and laryngopharynx using a new radiopharmaceutical based on technetium-99m-labeled gamma aluminum oxide
by: A. A. Medvedeva, et al.
Published: (2023-04-01)

The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations
by: A. S. Krylov, et al.
Published: (2020-04-01)

The role of <sup>18</sup>F-FDG PET/CT in evaluation of therapy effectiveness and prognosis of lymphomas
by: N. G. Chanchikova, et al.
Published: (2021-07-01)

Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
by: D. V. Goryachev, et al.
Published: (2025-02-01)

The First Application of Positron Emission Tomography/ Magnetic Resonance Imaging in Russia
by: A. S. Chaban, et al.
Published: (2019-06-01)

Erdheim–Chester disease. Literature review and clinical case
by: A. S. Krylov, et al.
Published: (2020-07-01)

Pharmacokinetic Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2022-12-01)

DIAGNOSING THE NATURE OF MYOCARDIAL CHANGES IN ITS CORONARY LESION
by: A. P. Borisenko, et al.
Published: (2001-04-01)

Synthesis and characterization of new complexes of Co+2 , Ni+2 , Cu+2 and Zn+2 with (Sodium acetate thio ) ethylene ligands
by: Baghdad Science Journal
Published: (2013-09-01)